MedPath

SPIROCOR Coronary Outcome by Respiratory Stress Examination

Terminated
Conditions
Severe Coronary Artery Disease (S-CAD)
Registration Number
NCT01053975
Lead Sponsor
Spirocor
Brief Summary

The purpose of this study is to validate the accuracy of the SPIROCOR System in indicating the presence of significant coronary artery disease (S-CAD), as defined in ACC/AHA Guidelines, in subjects with suspected S-CAD.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Subject with suspected S-CAD
  • Subject able to perform the guided breathing protocol and comply with study requirements
  • Subject is able and agrees to sign the informed consent form
Exclusion Criteria
  • Resting (supine) ECG evidence of ST-segment depression ≥ 1 mm in any lead or left bundle branch block or significant arrhythmia
  • Current digoxin therapy
  • Subject has severe valvular heart disease
  • Subject has congestive heart failure NYHA class III/IV
  • Subject has known history of myocardial infarction (ST elevation or non ST elevation)
  • Subject had previous coronary revascularization: CABG or PCI
  • Subject has pacemaker or ICD that controls sinus
  • Morbidly obese subject (BMI ≥ 40)
  • Subject has any significant medical condition which, at the investigator's discretion, may interfere with the subject's optimal participation in the study; and
  • Subject is currently participating in another investigational product clinical study that the investigator believes may interfere with the outcome of this study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
RSR vs. S-ECG in subjects suspected with S-CAD3 weeks window
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (26)

Minneapolis VAMC

🇺🇸

Minneapolis, Minnesota, United States

South Denver Heart Cardiology Associates

🇺🇸

Littleton, Colorado, United States

Cardiovascular Associates

🇺🇸

Louisville, Kentucky, United States

University of Alabama at Birmingham

🇺🇸

Birmingham, Alabama, United States

Heart Center Research

🇺🇸

Huntsville, Alabama, United States

Escondido Cardiology Associates

🇺🇸

Escondido, California, United States

Phoenix Heart, PLLC

🇺🇸

Glendale, Arizona, United States

Mount Sinai Medical Center

🇺🇸

Miami Beach, Florida, United States

Cardiovascular Research Center of South Florida

🇺🇸

Miami, Florida, United States

Cardiovascular Associates of the DE Valley - Cherry Hill

🇺🇸

Cherry Hill, New Jersey, United States

Christiana Care Health Services

🇺🇸

Newark, Delaware, United States

Catholic Medical Center

🇺🇸

Manchester, New Hampshire, United States

Cardiovascular Associates, DE Valley- Elmer

🇺🇸

Elmer, New Jersey, United States

Pentucket Medical Associates

🇺🇸

Haverhill, Massachusetts, United States

Cardiovascular Associates, DE Valley- Sewell

🇺🇸

Sewell, New Jersey, United States

North Ohio Research Ltd

🇺🇸

Elyria, Ohio, United States

Cardiac Diagnostic Associates, PC

🇺🇸

York, Pennsylvania, United States

Humility of Mary Health Partners dba, St. Elizabeth Health Center

🇺🇸

Youngstown, Ohio, United States

MUSC

🇺🇸

Charleston, South Carolina, United States

Clearwater Cardiovascular & Interventional Consultants

🇺🇸

Safety Harbor, Florida, United States

Cardiovascular Specialists of Central Maryland, PA

🇺🇸

Columbia, Maryland, United States

Cardiovascular Associates of East Texas

🇺🇸

Tyler, Texas, United States

University Of Iowa Hospital, Lipid Research Clinic

🇺🇸

Iowa City, Iowa, United States

The Linder Center for Research & Education

🇺🇸

Cincinnati, Ohio, United States

Cardiac & Endovascular Associates

🇺🇸

Ridgewood, New Jersey, United States

Sanford Cardiology, a division of Pinehurst Medical, Inc.

🇺🇸

Sanford, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath